Denali Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Denali Advisors's AZN Position: Q3 2026 in Review
Denali Advisors reduced its AstraZeneca (AZN) stake by 0.54% in Q3 2026, selling an estimated $6.33K and leaving 6,987 shares worth $1.13M. The position accounts for 0.11% of the portfolio, ranked #181.
Denali Advisors first reported a position in AZN in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.44M in Q1 2026. 1,429 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Denali Advisors held 6,987 shares of AstraZeneca worth $1.13M as of Q3 2026.
- Denali Advisors sold 38 AstraZeneca shares in Q3 2026, an estimated $6.33K.
- AstraZeneca made up 0.11% of Denali Advisors's portfolio in Q3 2026, its #181 holding.
- Denali Advisors first reported a position in AstraZeneca in Q3 2024 and has held it in 9 quarters since.
- Denali Advisors's AstraZeneca position peaked at $1.44M in Q1 2026.
- 1,429 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Denali Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.